Approved Symbol |
Approved Name |
Location |
Source |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
FGF4 |
fibroblast growth factor 4 |
11q13.3 |
Mapped by significant region |
FGF9 |
fibroblast growth factor 9 (glia-activating factor) |
13q11-q12 |
Mapped by significant region |
FN1 |
fibronectin 1 |
2q34 |
Mapped by significant region |
MAPK1 |
mitogen-activated protein kinase 1 |
22q11.2 |
Mapped by LD-proxy |
CYCS |
cytochrome c, somatic |
7p21.2 |
Mapped by CNV; Mapped by significant region |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
3q26 |
Mapped by PBA pathway |
APC |
adenomatous polyposis coli |
5q21-q22 |
Mapped by LD-proxy; Mapped by PBA pathway |
BAD |
BCL2-associated agonist of cell death |
11q13.1 |
Mapped by significant region |
TRAF1 |
TNF receptor-associated factor 1 |
9q33-q34 |
Mapped by significant region |
GSTP1 |
glutathione S-transferase pi 1 |
11q13.2 |
Mapped by significant region |
MAPK9 |
mitogen-activated protein kinase 9 |
5q35 |
Mapped by CNV |
STK36 |
serine/threonine kinase 36 |
2q35 |
Mapped by significant region |
VEGFB |
vascular endothelial growth factor B |
11q13 |
Mapped by significant region |
MAPK3 |
mitogen-activated protein kinase 3 |
16p11.2 |
Mapped by CNV |
BIRC2 |
baculoviral IAP repeat containing 2 |
11q22 |
Mapped by significant region |
BIRC3 |
baculoviral IAP repeat containing 3 |
11q22 |
Mapped by significant region |
LAMC2 |
laminin, gamma 2 |
1q25-q31 |
Mapped by significant region |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
1q31 |
Mapped by significant region |
LAMA3 |
laminin, alpha 3 |
18q11.2 |
Mapped by significant region |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
Mapped by significant region |
FGF3 |
fibroblast growth factor 3 |
11q13 |
Mapped by significant region |
FGF19 |
fibroblast growth factor 19 |
11q13.1 |
Mapped by significant region |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene spi1 |
11p12-p11.22 |
Mapped by LD-proxy |
LAMA2 |
laminin, alpha 2 |
6q22-q23 |
Mapped by CNV; Mapped by significant region |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
Mapped by significant region |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
5q11.2 |
Mapped by LD-proxy |
WNT11 |
wingless-type MMTV integration site family, member 11 |
11q13.5 |
Mapped by significant region |
WNT10A |
wingless-type MMTV integration site family, member 10A |
2q35 |
Mapped by significant region |
WNT6 |
wingless-type MMTV integration site family, member 6 |
2q35 |
Mapped by significant region |
CBL |
Cas-Br-M (murine) ecotropic retroviral transforming sequence |
11q23.3-qter |
Mapped by significant region |
IL6 |
interleukin 6 (interferon, beta 2) |
7p21-p15 |
Mapped by significant region |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
11q13 |
Mapped by significant region |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
11q21-q22 |
Mapped by significant region |
SKP2 |
S-phase kinase-associated protein 2 (p45) |
5p13 |
Mapped by significant region |
ZBTB16 |
zinc finger and BTB domain containing 16 |
11q23 |
Mapped by significant region |
CCND1 |
cyclin D1 |
11q13 |
Mapped by significant region |
CTNNA3 |
catenin (cadherin-associated protein), alpha 3 |
10q21 |
Mapped by CNV |
EGLN3 |
egl nine homolog 3 (C. elegans) |
14q12 |
Mapped by LD-proxy; Mapped by literature SNP |
CRKL |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
22q11.21 |
Mapped by CNV |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
17q11.2-q12 |
Mapped by LD-proxy |
TGFBR1 |
transforming growth factor, beta receptor 1 |
9q22 |
Mapped by significant region |
FADD |
Fas (TNFRSF6)-associated via death domain |
11q13.3 |
Mapped by significant region |
PTCH1 |
patched 1 |
9q22.1-q31 |
Mapped by significant region |
ETS1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
11q23.3 |
Mapped by significant region |
PIK3CG |
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
7q22 |
Mapped by CNV |
FZD4 |
frizzled family receptor 4 |
11q14-q21 |
Mapped by significant region |